Tufts-Center for the Evaluation of Value and Risk in Health (CEVR) is now accepting submissions for the annual CEVR Cost-Effectiveness Analysis (CEA) Paper of the Year Award.
Health care policy makers are increasingly seeking evidence on the value of health care to inform clinical guidelines and reimbursement decisions. At CEVR, we have seen a substantial rise in cost-effectiveness research being produced to meet this need. This award will highlight this important research and promote findings to a broad audience.
We will consider any original, applied CEA in the fields of health and medicine published in 2020 that reports results in terms of incremental cost per QALY gained or cost per DALY averted. We will judge articles based on:
- Timeliness and importance
- Methodological quality
- Potential influence on policy or clinical decision making
Editorials, commentaries, letters, point/counter-points, scientific reports, and economic analyses reporting endpoints other than cost per QALY or cost per DALY will not be considered.
Application Format and Submission
Anyone – including the authors themselves or any institution, can nominate a paper. To submit an article, please complete the online submission form by February 26, 2021. If you have any questions, please email firstname.lastname@example.org.
CEVR faculty and staff will select five finalists from among these submissions, and our CEA Registry Advisory Board (comprised of individuals from the life sciences industry, payers, academia, and government) will select the winner. The winner will be announced in June of 2021. The first author of the winning paper will receive an award of $1,000.